Aurobindo Pharma stock rises 2% on USFDA nod for nasal spray
Aurobindo Pharma: Early on March 20, Aurobindo Pharma’s stock price increased by almost 2 percent following the US Food & Drug Administration (USFDA)’s approval of the company’s nasal spray. Aurobindo Pharma was trading at Rs 1,003.90 on the BSE at 9:18 a.m., up Rs 14.50, or 1.47 percent. According to a press release, the company…